The effect of cardiac remote ischemic preconditioning (IRPC) on the release of cardiac troponin I after elective percutaneous coronary intervention (PCI)
Not Applicable
- Conditions
- Ischemic heart disease.Acute ischemic heart disease, unspecifiedI24.9
- Registration Number
- IRCT20180306038978N1
- Lead Sponsor
- Bandare-abbas University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 240
Inclusion Criteria
Age of 18 years or older
Stable coronary artery disease
Requirement of elective PCI
Exclusion Criteria
Emergency PCI
Renal dysfucntion
High cardiac troponin levels before PCI
Women of childbearing age
Use of Nicorandil or Glibenclamide
Severe comorbidities (terminal illnesses, advanced cancers with low life expectancy, renal failure, hepatic failure, rheumatic diseases)
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cardiac troponin I. Timepoint: Cardiac troponin I is measured right before and 18 hours after percutaneous coronary intervention. Method of measurement: Quantitative measurement of cardiac troponin I using enzymatic method.
- Secondary Outcome Measures
Name Time Method